These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 27899256)

  • 21. Targeting HSP90/Survivin using a cell permeable structure based peptido-mimetic shepherdin in retinoblastoma.
    Venkatesan N; Kanwar JR; Deepa PR; Navaneethakrishnan S; Joseph C; Krishnakumar S
    Chem Biol Interact; 2016 May; 252():141-9. PubMed ID: 27062892
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Artesunate exerts specific cytotoxicity in retinoblastoma cells via CD71.
    Zhao F; Wang H; Kunda P; Chen X; Liu QL; Liu T
    Oncol Rep; 2013 Sep; 30(3):1473-82. PubMed ID: 23818062
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression Changes and Impact of the Extracellular Matrix on Etoposide Resistant Human Retinoblastoma Cell Lines.
    Reinhard J; Wagner N; Krämer MM; Jarocki M; Joachim SC; Dick HB; Faissner A; Kakkassery V
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32560557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of MMP-2 and MMP-9 decreases cellular migration, and angiogenesis in in vitro models of retinoblastoma.
    Webb AH; Gao BT; Goldsmith ZK; Irvine AS; Saleh N; Lee RP; Lendermon JB; Bheemreddy R; Zhang Q; Brennan RC; Johnson D; Steinle JJ; Wilson MW; Morales-Tirado VM
    BMC Cancer; 2017 Jun; 17(1):434. PubMed ID: 28633655
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurokinin-1 activation affects EGFR related signal transduction in triple negative breast cancer.
    Wang JG; Yu J; Hu JL; Yang WL; Ren H; Ding D; Zhang L; Liu XP
    Cell Signal; 2015 Jul; 27(7):1315-24. PubMed ID: 25817575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tyr1068-phosphorylated epidermal growth factor receptor (EGFR) predicts cancer stem cell targeting by erlotinib in preclinical models of wild-type EGFR lung cancer.
    Sette G; Salvati V; Mottolese M; Visca P; Gallo E; Fecchi K; Pilozzi E; Duranti E; Policicchio E; Tartaglia M; Milella M; De Maria R; Eramo A
    Cell Death Dis; 2015 Aug; 6(8):e1850. PubMed ID: 26247735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular mechanisms underlying the synergistic interaction of erlotinib, an epidermal growth factor receptor tyrosine kinase inhibitor, with the multitargeted antifolate pemetrexed in non-small-cell lung cancer cells.
    Giovannetti E; Lemos C; Tekle C; Smid K; Nannizzi S; Rodriguez JA; Ricciardi S; Danesi R; Giaccone G; Peters GJ
    Mol Pharmacol; 2008 Apr; 73(4):1290-300. PubMed ID: 18187583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histone deacetylase inhibitor, AR-42, exerts antitumor effects by inducing apoptosis and cell cycle arrest in Y79 cells.
    Duan S; Gong X; Liu X; Cui W; Chen K; Mao L; Jun S; Zhou R; Sang Y; Huang G
    J Cell Physiol; 2019 Dec; 234(12):22411-22423. PubMed ID: 31102271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lidocaine inhibits the progression of retinoblastoma in vitro and in vivo by modulating the miR‑520a‑3p/EGFR axis.
    Xia W; Wang L; Yu D; Mu X; Zhou X
    Mol Med Rep; 2019 Aug; 20(2):1333-1342. PubMed ID: 31173241
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Crocin inhibits proliferation and induces apoptosis through suppressing MYCN expression in retinoblastoma.
    Deng L; Li J; Lu S; Su Y
    J Biochem Mol Toxicol; 2019 May; 33(5):e22292. PubMed ID: 30672053
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Phosphorylated JNK mediated apoptosis induced by all trans retinoid acid in human retinoblastoma cell line].
    Min HB; Wang JW; Sun JH; Bu SZ; Huang Q
    Zhonghua Zhong Liu Za Zhi; 2003 Mar; 25(2):130-3. PubMed ID: 12795836
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The pan-HDAC inhibitor panobinostat acts as a sensitizer for erlotinib activity in EGFR-mutated and -wildtype non-small cell lung cancer cells.
    Greve G; Schiffmann I; Pfeifer D; Pantic M; Schüler J; Lübbert M
    BMC Cancer; 2015 Dec; 15():947. PubMed ID: 26675484
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapamycin, a mTOR inhibitor, induced growth inhibition in retinoblastoma Y79 cell via down-regulation of Bmi-1.
    Wang YD; Su YJ; Li JY; Yao XC; Liang GJ
    Int J Clin Exp Pathol; 2015; 8(5):5182-8. PubMed ID: 26191215
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subconjunctival topotecan in fibrin sealant in the treatment of transgenic murine retinoblastoma.
    Tsui JY; Dalgard C; Van Quill KR; Lee L; Grossniklaus HE; Edelhauser HF; O'Brien JM
    Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):490-6. PubMed ID: 18234990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methylene blue-mediated Photodynamic Therapy in human retinoblastoma cell lines.
    Turchiello RF; Oliveira CS; Fernandes AU; Gómez SL; Baptista MS
    J Photochem Photobiol B; 2021 Sep; 222():112260. PubMed ID: 34304071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of a selective cyclooxygenase-2 (COX-2) inhibitor on the proliferation rate of retinoblastoma cell lines.
    de Souza Filho JP; Correa ZM; Marshall JC; Anteka E; Coutinho AB; Martins MC; Burnier MN
    Eye (Lond); 2006 May; 20(5):598-601. PubMed ID: 16123787
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Bcl-2/Bcl-XL inhibitor ABT-737 promotes death of retinoblastoma cancer cells.
    Allaman-Pillet N; Oberson A; Munier F; Schorderet DF
    Ophthalmic Genet; 2013; 34(1-2):1-13. PubMed ID: 21955141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro effects of radiation on human retinoblastoma cells.
    Zhang M; Stevens G; Madigan MC
    Int J Cancer; 2001; 96 Suppl():7-14. PubMed ID: 11992382
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Global gene deregulations in FASN silenced retinoblastoma cancer cells: molecular and clinico-pathological correlations.
    Sangeetha M; Deepa PR; Rishi P; Khetan V; Krishnakumar S
    J Cell Biochem; 2015 Nov; 116(11):2676-94. PubMed ID: 25958981
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the in vitro and in vivo antitumor activity of histone deacetylase inhibitors for the therapy of retinoblastoma.
    Dalgard CL; Van Quill KR; O'Brien JM
    Clin Cancer Res; 2008 May; 14(10):3113-23. PubMed ID: 18483379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.